Myriad Genetics, Inc. (MYGN)

USD 13.25

(-4.12%)

Total Debt Summary of Myriad Genetics, Inc.

  • Myriad Genetics, Inc.'s latest annual total debt in 2022 was 145 Million USD , up 57.1% from previous year.
  • Myriad Genetics, Inc.'s latest quarterly total debt in 2023 Q2 was 203.8 Million USD , up 26.11% from previous quarter.
  • Myriad Genetics, Inc. reported annual total debt of 92.3 Million USD in 2021, down 0.0% from previous year.
  • Myriad Genetics, Inc. reported annual total debt of - USD in 2020, down -100.0% from previous year.
  • Myriad Genetics, Inc. reported quarterly total debt of 161.6 Million USD for 2023 Q1, up 11.45% from previous quarter.
  • Myriad Genetics, Inc. reported quarterly total debt of 203.8 Million USD for 2023 Q2, up 26.11% from previous quarter.

Annual Total Debt Chart of Myriad Genetics, Inc. (2022 - 1995)

Historical Annual Total Debt of Myriad Genetics, Inc. (2022 - 1995)

Year Total Debt Total Debt Growth
2022 145 Million USD 57.1%
2021 92.3 Million USD 0.0%
2020 - USD -100.0%
2019 233.5 Million USD 0.0%
2018 233.5 Million USD 2410.75%
2017 9.3 Million USD -90.62%
2016 99.1 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD -100.0%
1997 100 Thousand USD -75.0%
1996 400 Thousand USD -50.0%
1995 800 Thousand USD 0.0%

Peer Total Debt Comparison of Myriad Genetics, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD -64.872%
Prenetics Global Limited 2.36 Million USD -6019.724%
Star Equity Holdings, Inc. 3.6 Million USD -3917.733%
CareDx, Inc 34.22 Million USD -323.716%
Exact Sciences Corporation 2.55 Billion USD 94.324%
Exagen Inc. 23.72 Million USD -511.273%
Inotiv, Inc. 417.64 Million USD 65.281%
Guardant Health, Inc. 1.35 Billion USD 89.289%
Biodesix, Inc. 60.69 Million USD -138.915%
BioNexus Gene Lab Corp. 133.39 Thousand USD -108599.726%
Precipio, Inc. 1.11 Million USD -12892.832%
iSpecimen Inc. 196.24 Thousand USD -73787.609%
Natera, Inc. 441.99 Million USD 67.194%
Aspira Women's Health Inc. 2.26 Million USD -6298.941%
Standard BioTools Inc. 98.21 Million USD -47.643%
23andMe Holding Co. 76.51 Million USD -89.505%
Castle Biosciences, Inc. 15.31 Million USD -847.093%
Personalis, Inc. 48.96 Million USD -196.148%
Aclaris Therapeutics, Inc. 426 Thousand USD -33937.559%
Applied DNA Sciences, Inc. 1.23 Million USD -11614.71%
OpGen, Inc. 13.04 Million USD -1011.647%
T2 Biosystems, Inc. 49.49 Million USD -192.941%
ICON Public Limited Company 3.93 Billion USD 96.318%
NeoGenomics, Inc. 611.67 Million USD 76.295%
Star Equity Holdings, Inc. 3.6 Million USD -3917.733%
IDEXX Laboratories, Inc. 947.88 Million USD 84.703%
RadNet, Inc. 1.49 Billion USD 90.276%
MDxHealth SA 41.26 Million USD -251.387%
Psychemedics Corporation 2.29 Million USD -6209.835%
Illumina, Inc. 2.26 Billion USD 93.59%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD -54.142%
DarioHealth Corp. 29.54 Million USD -390.843%
Fulgent Genetics, Inc. 14.9 Million USD -872.697%
Sera Prognostics, Inc. 1.85 Million USD -7704.09%
ENDRA Life Sciences Inc. 394.4 Thousand USD -36664.426%
OPKO Health, Inc. 326.56 Million USD 55.598%
Medpace Holdings, Inc. 142.12 Million USD -2.025%
Neogen Corporation 906.23 Million USD 84.0%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -16539.126%
Prenetics Global Limited 2.36 Million USD -6019.724%
Mainz Biomed B.V. 7.42 Million USD -1853.972%
bioAffinity Technologies, Inc. 1.57 Million USD -9085.127%
Trinity Biotech plc 67.42 Million USD -115.047%
Neuronetics, Inc. 62.47 Million USD -132.097%
Sotera Health Company 2.32 Billion USD 93.769%
bioAffinity Technologies, Inc. 1.57 Million USD -9085.127%